Conforma Gets Confirmation: Modern methods validate an old-fashioned discovery approach
This article was originally published in Start Up
Executive Summary
Conforma Therapeutics' recent research finding may well inspire other companies to combine the best of traditional and new drug discovery methods: the start-up identified an old, natural compound by its physiological properties, then through modern technologies deduced the reason that it works.
You may also be interested in...
Wanted: Drug Hunters
The process of hunting for drugs is now markedly different than it was a few decades ago, partly because research organizations are much bigger and market pressures more intense. Technology has catalyzed the biggest shifts, decreasing the role of individuals and putting more emphasis on method than conceptualization. But the high-tech methods haven't been as productive as expected, and so research executives are increasingly considering which of the traditional ways might be worth recapturing.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.